News
A single dose of RSVPreF3 OA offered protection against RSV-related lower respiratory tract disease across three RSV seasons ...
The FDA greenlit multiple new drugs this month and issued some notable label expansions including for Eli Lilly’s Kisunla.
Shares of GSK PLC GSK slid 3.04% to £14.18 Thursday, on what proved to be an all-around rough trading session for the stock ...
The prefilled syringe presentation offers a convenient administration option to healthcare professionals.
The biopharmaceutical industry is growing rapidly as a result of significant advancements in biotechnology and drug development. Due to developments in ...
BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that its president and chief executive officer, Jon Stonehouse, has informed the board of directors of his intention to retire on December ...
The U.S. Asthma Treatment Market to Reach USD 10.81 Billion by 2032, Driven by Improved Inhalation Therapies, Precision Medicine, and Growing Awareness of Chronic Respiratory Conditions.Austin, July ...
WuxiAppTec raised HK$7.70 billion (US$981 million) in a sale of additional shares to fund its global expansion.
The case illustrates the evolving practice of the CNIPA concerning requests for review of refusal decisions based on ...
GSK’s anti-TIM monoclonal antibody (mAb) cobolimab has failed a Phase III trial in non-small cell lung cancer (NSCLC). The ...
The global chicken pox market is experiencing significant growth driven by the widespread prevalence of the varicella-zoster virus, low vaccination rates in certain regions, and increasing awareness ...
Artificial intelligence (AI) is already transforming scientific research and the development of novel pharmaceutical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results